Alan_Watt

Cellzome hires GSK’s Alan Watt

pharmafile | September 20, 2010 | Appointment | Research and Development Cellzome, appointment, research and development 

Cambridge, UK-based drug discovery and development company Cellzome has appointed Alan Watt to its senior management team as vice president of therapeutics.

Alan joins the company from GlaxoSmithKline, where he was most recently vice president of the company’s Immuno-Inflammation Centre of Excellence for Drug Discovery.

Prior to his time with GSK Alan held various positions at Merck Sharp & Dohme, starting as medicinal chemist, moving into analytical chemistry and finally leading the drug metabolism department as senior director until he left in 2006.

Advertisement

Cellzome’s chief executive Tim Edwards said: “We are delighted that Alan has joined Cellzome. In his 25 years of experience in the industry he has delivered numerous development candidates into the clinic. His experience will help us to fully leverage our chemical proteomics platform.”

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …

The Gateway to Local Adoption Series

Latest content